These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 15462612)

  • 21. Statins and bone metabolism.
    Horiuchi N; Maeda T
    Oral Dis; 2006 Mar; 12(2):85-101. PubMed ID: 16476028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statins and cardioprotection--more than just lipid lowering?
    Ludman A; Venugopal V; Yellon DM; Hausenloy DJ
    Pharmacol Ther; 2009 Apr; 122(1):30-43. PubMed ID: 19318042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanisms of action of statins and their pleiotropic effects].
    Davignon J; Mabile L
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 2):101-12. PubMed ID: 11240412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of statins as potential targets for bone formation.
    Garrett IR; Mundy GR
    Arthritis Res; 2002; 4(4):237-40. PubMed ID: 12106493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HMG-CoA reductase inhibitors in osteoporosis: do they reduce the risk of fracture?
    Schlienger RG; Meier CR
    Drugs Aging; 2003; 20(5):321-36. PubMed ID: 12696993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulatory effects of HMG-CoA reductase inhibitors in diabetic microangiopathy.
    Danesh FR; Kanwar YS
    FASEB J; 2004 May; 18(7):805-15. PubMed ID: 15117885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Statins and endothelial dysfunction].
    Filip-Ciubotaru FM; Manciuc C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):975-83. PubMed ID: 20191862
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically relevant pleiotropic effects of statins: drug properties or effects of profound cholesterol reduction?
    Comparato C; Altana C; Bellosta S; Baetta R; Paoletti R; Corsini A
    Nutr Metab Cardiovasc Dis; 2001 Oct; 11(5):328-43. PubMed ID: 11887430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison between the effects of hydrophobic and hydrophilic statins on osteoclast function in vitro and ovariectomy-induced bone loss in vivo.
    Hughes A; Rogers MJ; Idris AI; Crockett JC
    Calcif Tissue Int; 2007 Nov; 81(5):403-13. PubMed ID: 17982704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitric oxide as the mediator of the antiosteoporotic actions of estrogen, statins, and essential fatty acids.
    Das UN
    Exp Biol Med (Maywood); 2002 Feb; 227(2):88-93. PubMed ID: 11815671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translating the effects of statins: from redox regulation to suppression of vascular wall inflammation.
    Antonopoulos AS; Margaritis M; Shirodaria C; Antoniades C
    Thromb Haemost; 2012 Nov; 108(5):840-8. PubMed ID: 22872079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pleiotropic effects of statins: evidence against benefits beyond LDL-cholesterol lowering.
    Pedersen TR
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():10-7. PubMed ID: 21391729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
    Robinson JG
    Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pleiotropic effects of statins: evidence for benefits beyond LDL-cholesterol lowering.
    Marzilli M
    Am J Cardiovasc Drugs; 2010; 10 Suppl 1():3-9. PubMed ID: 21391728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Statins and the endothelium.
    Ii M; Losordo DW
    Vascul Pharmacol; 2007 Jan; 46(1):1-9. PubMed ID: 16920035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bone metabolism and cardiovascular function update. Cross link of hypertension, bone loss and vascular calcification - common back grounds in renin angiotensin system with anti-aging aspect -].
    Shimizu H; Nakagami H; Morishita R
    Clin Calcium; 2014 Jul; 24(7):53-62. PubMed ID: 24976056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statins Therapy for Connective Tissue Diseases: New Therapeutic Opportunities.
    Kotyla PJ; Kucharz EJ
    Endocr Metab Immune Disord Drug Targets; 2018 Feb; 18(2):135-147. PubMed ID: 29149821
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pleiotropic effects of HMG-CoA reductase inhibitors.
    Bocan TM
    Curr Opin Investig Drugs; 2002 Sep; 3(9):1312-7. PubMed ID: 12498006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HIV infection, antiretroviral therapy, and endothelium].
    Hürlimann D; Weber R; Enseleit F; Lüscher TF
    Herz; 2005 Sep; 30(6):472-80. PubMed ID: 16170677
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rho GTPases, statins, and nitric oxide.
    Rikitake Y; Liao JK
    Circ Res; 2005 Dec; 97(12):1232-5. PubMed ID: 16339495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.